GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CME Group CME · USD

Financials · Capital Markets · US listing · 🇺🇸 United States

S&P 500

Compare

304.52

-0.45%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue, before interest expense

$6.52bn

FY2016FY2025

Net income

$4.04bn

FY2016FY2025

Total assets

$198.55bn

FY2016FY2025

Shareholders' equity

$28.73bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue, before interest expense$6.52bn$6.13bn$5.58bn$5.02bn$4.69bn$4.88bn$4.87bn$4.31bn$3.64bn$3.60bn
Research and development——$218.7m$188.6m$192.6m$198.5m$201.5m$117.2m$101.6m$97.6m
Operating income$5.45bn$4.70bn$3.60bn$3.65bn$2.81bn$2.89bn$1.06bn$1.42bn$1.52bn$1.15bn
Net income$4.04bn$3.53bn$3.23bn$2.69bn$2.64bn$2.11bn$2.12bn$1.96bn$4.06bn$1.53bn
Diluted earnings per share11.239.798.977.497.345.875.915.5711.934.52

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$198.55bn$137.45bn$129.71bn$174.18bn$196.78bn$124.66bn$75.22bn$77.48bn$75.79bn$69.37bn
Cash and short-term investments$4.55bn$3.01bn$3.02bn$2.82bn$2.95bn$1.73bn$1.63bn$1.45bn$1.99bn$1.95bn
Total liabilities$169.82bn$110.96bn$102.97bn$147.30bn$169.38bn$98.31bn$49.06bn$51.51bn$53.38bn$49.03bn
Debt$3.42bn$3.49bn$3.49bn$3.51bn$3.53bn$3.54bn$3.84bn$4.40bn$2.23bn$2.23bn
Shareholders' equity$28.73bn$26.49bn$26.74bn$26.88bn$27.40bn$26.35bn$26.16bn$25.92bn$22.41bn$20.34bn
Shares outstanding360m360m360m359m359m359m358m352m340m339m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue, before interest expense$1.71bn$1.88bn$1.65bn$1.54bn$1.69bn$1.64bn$1.53bn$1.58bn
Operating income$1.11bn$1.55bn$1.56bn$972.6m$1.37bn$1.29bn$947.1m$1.22bn
Net income$1.04bn$1.15bn$1.17bn$908.0m$1.01bn$956.2m$874.6m$912.8m
Diluted earnings per share2.883.193.242.522.812.652.432.54
Total assets$194.68bn$201.99bn$198.55bn$187.14bn$179.91bn$157.83bn$137.45bn$137.80bn
Cash and short-term investments$2.28bn$2.52bn$4.55bn$2.57bn$2.10bn$1.52bn$3.01bn$2.43bn
Debt—$3.42bn$3.48bn$3.48bn$3.47bn$3.42bn$3.43bn$3.43bn
Shareholders' equity$26.52bn$26.62bn$28.73bn$28.19bn$27.74bn$27.03bn$26.49bn$28.22bn

Financial ratios

Data as of 8 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin83.5%76.7%64.4%72.8%60.0%59.1%——
Net margin62.0%57.5%57.8%53.6%56.2%43.1%——
Return on equity14.1%13.3%12.1%10.0%9.6%8.0%——
Return on assets2.0%2.6%2.5%1.5%1.3%1.7%——
Revenue growth6.4%9.9%11.1%7.0%-4.0%0.3%——
Earnings growth14.7%9.3%19.9%2.1%25.2%-0.5%——
Current ratio0.03x1.01x1.02x1.01x1.01x1.01x——
Debt to equity0.12x0.13x0.13x0.13x0.13x0.13x——
Equity ratio14.5%19.3%20.6%15.4%13.9%21.1%——
Interest coverage41.98x29.22x22.56x22.45x16.85x17.38x——
R&D as a share of sales——3.9%3.8%4.1%4.1%4.1%2.7%
Buybacks as a share of market value-0.1%-0.1%-0.1%-0.0%-0.1%-0.1%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.1%6.0%7.0%
Operating income14.2%13.5%10.6%
Net income14.5%13.9%12.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin80.2%74.8%70.4%57.5%
Net margin59.8%58.0%55.5%55.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings24.323.723.522.431.131.034.033.812.225.5
Price to sales15.113.613.612.017.513.414.815.413.610.9

Market value over time

31 Oct 2016 to 4 Sept 2026, in USD

$33.93bn$101.89bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return12%11%25%-23%22%-9%9%25%23%34%

Dividends and splits

Per share, in the currency the company pays

Paid for 23 years. Last went ex-dividend on 9 Sept 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year3.905.0010.409.658.506.855.905.50
  • 5-for-1 split · 23 Jul 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.